Tim Moran

Tim Moran is a prominent entrepreneur and executive with extensive experience in pediatric medical device development. As Founder and CEO of PediaStent since 2012, Tim is leading the development of CardiaZn, a pioneering bioresorbable metallic stent for treating congenital heart defects in neonates, recognized by the FDA as a Break Through Technology in 2023. Additionally, Tim founded PediaVascular in 2010, which has successfully treated over 80,000 infants in 25 countries with innovative angiography devices. With leadership roles at PediaWorks, the Midwest Pediatric Device Consortium, and PolyVascular, Tim has made significant contributions to the pediatric healthcare sector. Tim’s previous experience includes founding CSF Therapeutics and serving as Entrepreneur in Residence at Cleveland Clinic. Tim holds an MBA from Northwestern University's Kellogg School of Management and a BS in Finance from Miami University.